Express Healthcare

Foundation stone of India’s first exclusive medical device manufacturing park laid

233

The 270-acre Andhra Pradesh MedTech Zone will have state-of-the-art and the best global facilities for R&D, manufacturing, testing, export and regulatory facilitations and logistics

The foundation stone of India’s first exclusive medical device manufacturing park, Andhra Pradesh MedTech Zone (AMTZ), was laid at Nadupur village of Pedda Gantyada Mandal in Vishakhapatnam by Chandrababu Naidu, Chief Minister, Andhra Pradesh. Also present were Union Ministers Venkaiah Naidu, Ananth Kumar, Kameini Srinivas, Health Minister, Andhra Pradesh, Henk Bekedam, WHO Representative to India and representatives from Indian medical device industry. Rajiv Nath, Forum Coordinator, AiMeD was also present during the event.

AMTZ, the 270-acre exclusive manufacturing zone is the result of MoU signed between the state government and AiMeD nine months back with a view to promote manufacturing of high-tech and high-end medical devices within the country. The zone will have state-of-the-art and the best global facilities for R&D, manufacturing, testing, export and regulatory facilitations and logistics. It will house 200 medical devices manufacturing units.

“The AMTZ project will be a game changer for India in the field of healthcare. This has global consequences, from being Pharmacy of the World to being the Medical Devices Manufacturing Hub of the World,” said Bekedam.

“The launch of AMTZ is the dawn of a new era in the history of medical devices and electronic industry in India. “Medical device manufacturing could be the next big thing for Indian economy after the IT revolution. This facility is not only a big milestone for the country which will catapult India into the league of top medical equipment producing countries in the world but equally important it will help bring down overall healthcare cost while ensuring tremendous saving in terms of foreign exchange,” said Rajiv Nath, Forum Coordinator, AiMeD.

EH News Bureau

- Advertisement -

Comments are closed.